سعر فلوبادكس 4مجم 20 كبسولة 2024

Silodosin 4 mg capsules, pack of 20 (2 strips), by Eva Pharma (Egypt); selective alpha-1A blocker for urinary symptoms of benign prostatic hyperplasia.

• Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH); not indicated for the treatment of hypertension.Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common (more than 2%): retrograde ejaculation, dizziness, diarrhoea, orthostatic hypotension, headache, nasopharyngitis and nasal congestion.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Severe renal impairment (CrCl below 30 ml/min).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Severe hepatic impairment (Child-Pugh score 10 or more).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant strong CYP3A4 inhibitors (e.g. ketoconazole, clarithromycin, itraconazole, ritonavir).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Postural hypotension, with or without symptoms such as dizziness, may develop when starting treatment.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Do not combine with other alpha-blockers.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Examine patients before starting to rule out prostate carcinoma.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, itraconazole, ritonavir)Contraindicated: raise silodosin levels.DailyMed (U.S. National Library of Medicine)
• Strong P-glycoprotein inhibitors (e.g. ciclosporin)May increase silodosin levels; concomitant use not recommended.DailyMed (U.S. National Library of Medicine)
• Other alpha-blockersInteractions expected; concomitant use not recommended.DailyMed (U.S. National Library of Medicine)

• Silodosin is not indicated for use in females.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Silodosin is not indicated for use in females.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Silodosin: Selective antagonist of post-synaptic alpha-1 adrenoreceptors (high affinity for the alpha-1A subtype) in the prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra; smooth-muscle relaxation improves urine flow and BPH symptoms (US silodosin label).